Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Genetic Technologies ( (AU:GTG) ) is now available.
Genetic Technologies Limited has appointed Campbell Welch as a director effective 24 March 2026, and lodged the required initial director’s interest notice with the ASX. The filing confirms that Welch currently holds no relevant interests in the company’s securities and has no related securities contracts, indicating no immediate change to the firm’s capital or ownership structure from this board appointment.
The most recent analyst rating on (AU:GTG) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Genetic Technologies stock, see the AU:GTG Stock Forecast page.
More about Genetic Technologies
Genetic Technologies Limited is a listed company in the biotechnology and genetics sector, operating under Australian corporate and securities regulations. The company’s shares are traded on the ASX, where it complies with disclosure requirements regarding directors’ interests and corporate governance matters.
Technical Sentiment Signal: Sell
Current Market Cap: A$5.67M
For detailed information about GTG stock, go to TipRanks’ Stock Analysis page.